Cardio Diagnostics Holdings, Inc. (CDIOW) stock
CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $4.94MP/E –Yield –
Cardio Diagnostics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cardio Diagnostics's revenue for the twelve months ending Dec 31, 2025 was $14.83K, down 57.5% year over year. For fiscal 2025 it was $14.83K, down 57.5% from the year before. The highest annual figure on record is $34.89K in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.83K | -57.5% |
| FY2024 | Dec 31, 2024 | $34.89K | +104.5% |
| FY2023 | Dec 31, 2023 | $17.07K | +1696.3% |
| FY2022 | Dec 31, 2022 | $950 | +5.4% |
| FY2021 | Dec 31, 2021 | $901 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.36K | +18.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.68K | -59.3% |
| Q4 FY2025 | Dec 31, 2025 | $3.56K | -54.8% |
| Q1 FY2025 | Mar 31, 2025 | $940 | -94.1% |
| Q4 FY2024 | Dec 31, 2024 | $4.51K | -15.0% |
| Q3 FY2024 | Sep 30, 2024 | $6.58K | -34.4% |
| Q2 FY2024 | Jun 30, 2024 | $7.87K | +356.2% |
| Q1 FY2024 | Mar 31, 2024 | $15.93K | – |
| Q4 FY2023 | Dec 31, 2023 | $5.31K | – |
| Q3 FY2023 | Sep 30, 2023 | $10.03K | – |
| Q2 FY2023 | Jun 30, 2023 | $1.73K | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |